LLY
738.06
+1.61%↑
JNJ
178.12
-0.03%↓
ABBV
209.99
-1.09%↓
UNH
320.2
+1.63%↑
NVO
54.31
-1.47%↓
LLY
738.06
+1.61%↑
JNJ
178.12
-0.03%↓
ABBV
209.99
-1.09%↓
UNH
320.2
+1.63%↑
NVO
54.31
-1.47%↓
LLY
738.06
+1.61%↑
JNJ
178.12
-0.03%↓
ABBV
209.99
-1.09%↓
UNH
320.2
+1.63%↑
NVO
54.31
-1.47%↓
LLY
738.06
+1.61%↑
JNJ
178.12
-0.03%↓
ABBV
209.99
-1.09%↓
UNH
320.2
+1.63%↑
NVO
54.31
-1.47%↓
LLY
738.06
+1.61%↑
JNJ
178.12
-0.03%↓
ABBV
209.99
-1.09%↓
UNH
320.2
+1.63%↑
NVO
54.31
-1.47%↓
24h
Current
Min
14.05
Max
14.6
Recommendations | Buy |
---|---|
12 Months Forecast | +108.48% upside |
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
19 gru 2024, 00:26 UTC
Mesoblast ADRs Rise 22%, FDA Approves Ryoncil for Pediatric Patients -- Update
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 30 USD 108.48%
High 30 USD
Low 30 USD
Based on 3 Wall Street analysts offering 12 month price targets forMesoblast Ltd ADR - Dist in the last 3 months.
By TipRanks
Buy
3 ratings
2
Buy
1
Hold
0
Sell
Based on 3 analysts giving stock ratings to Mesoblast Ltd ADR - Dist in the past 3 months.
$